Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...
Read Full NewsResearch reveals a significant skin-brain connection, linking inflammatory skin diseases to neurocognitive and emotional health, particularly in children with atopic dermatitis.
The REVISE trial, a phase 2 study evaluating GenSight Biologics’ lenadogene nolparvovec in patients with Leber hereditary optic neuropathy, is expected to begin in January 2026.
Intellia’s trial for nex-z in ATTR-CM remains under clinical hold.
Arai breaks down key recommendations from the 2025 AGA gastroparesis guidelines and what they mean for the field at large.
IMMpactful: Risankizumab Shows Greater Clinical Response to Deucravacitinib in Psoriasis
1.
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis
2.
UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms
3.
Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer
4.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
5.
Beyond What Is Visible in Myelofibrosis?
1.
A Closer Look at MCV Modules: Features, Functions, and Benefits
2.
The benefits of using magnesium sulfate during pregnancy
3.
The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide
4.
Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer
5.
Cancer Vaccines In India: The Latest Hope In The Fight Against Disease
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VII
2.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
4.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
5.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge